Gomes C, Agg B, Andova A, Arslan S, Baker A, Barteková M, et al
. Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129. Noncoding RNA. 2019;5: pubmed publisher
..COST (European Cooperation in Science and Technology) is a funding organization for research and innovation networks (www.cost.eu). ..
Lázár B, Brenner G, Makkos A, Balogh M, László S, Al Khrasani M, et al
. Lack of Small Intestinal Dysbiosis Following Long-Term Selective Inhibition of Cyclooxygenase-2 by Rofecoxib in the Rat. Cells. 2019;8: pubmed publisher
..Moreover, inhibition of COX-2 activity is not likely to be responsible per se for microbial alterations caused by some coxibs, but other drug-specific properties may contribute to it. ..
Bencsik P, Kiss K, Agg B, Baán J, Agoston G, Varga A, et al
. Sensory Neuropathy Affects Cardiac miRNA Expression Network Targeting IGF-1, SLC2a-12, EIF-4e, and ULK-2 mRNAs. Int J Mol Sci. 2019;20: pubmed publisher
..These results further support the need for unbiased omics approach followed by in silico prediction and validation of molecular targets to reveal novel pathomechanisms. ..
Madonna R, Balistreri C, De Rosa S, Muscoli S, Selvaggio S, Selvaggio G, et al
. Impact of Sex Differences and Diabetes on Coronary Atherosclerosis and Ischemic Heart Disease. J Clin Med. 2019;8: pubmed publisher
..We analyze whether sex may modify the effects of diabetes at risk of CAD. Finally, we discuss current diagnostic techniques in the evaluation of CAD and IHD in diabetic women. ..
Poz D, De Falco E, Pisano C, Madonna R, Ferdinandy P, Balistreri C. Diagnostic and prognostic relevance of Red blood cell distribution width for vascular aging and cardiovascular diseases. Rejuvenation Res. 2018;: pubmed publisher
Madonna R, Cadeddu C, Deidda M, Giricz Z, Madeddu C, Mele D, et al
. Cardioprotection by gene therapy: A review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology. Int J Cardiol. 2015;191:203-10 pubmed publisher
..We discuss signaling pathways associated with cardioprotection that can be targeted by gene therapy to achieve cardioprotection. ..
Agg B, Baranyai T, Makkos A, Vető B, Faragó N, Zvara A, et al
. MicroRNA interactome analysis predicts post-transcriptional regulation of ADRB2 and PPP3R1 in the hypercholesterolemic myocardium. Sci Rep. 2018;8:10134 pubmed publisher
SÃ¡rkÃ¶zy M, SzÅ±cs G, Pipicz M, Zvara Ã, Ã‰der K, Fekete V, et al
. The effect of a preparation of minerals, vitamins and trace elements on the cardiac gene expression pattern in male diabetic rats. Cardiovasc Diabetol. 2015;14:85 pubmed publisher
..Our results and further studies exploring the mechanistic role of individual genes may contribute to the prevention or diagnosis of cardiac complications in diabetes. ..
Bencsik P, Pálóczi J, Kocsis G, Pipis J, Belecz I, Varga Z, et al
. Moderate inhibition of myocardial matrix metalloproteinase-2 by ilomastat is cardioprotective. Pharmacol Res. 2014;80:36-42 pubmed publisher
..Furthermore, this is the first demonstration that a moderate inhibition of intracellular MMP-2 is sufficient to confer cardiocytoprotection. ..